A multi-institutional cohort study of adjuvant therapy in stage I–II uterine carcinosarcoma
- 31 October 2012
- journal article
- research article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 127 (1), 22-26
- https://doi.org/10.1016/j.ygyno.2012.06.020
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Uterine CarcinosarcomaClinical Obstetrics and Gynecology, 2011
- The impact of multi-modal therapy on survival for uterine carcinosarcomasGynecologic Oncology, 2010
- Patterns of Failure for Conservatively Managed Surgical Stage I Uterine CarcinosarcomaInternational Journal of Gynecologic Cancer, 2009
- The role of radiation in improving survival for early-stage carcinosarcoma and leiomyosarcomaAmerican Journal of Obstetrics and Gynecology, 2008
- Uterine Carcinosarcomas and Grade 3 Endometrioid CancersObstetrics & Gynecology, 2008
- Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: An European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874)European Journal of Cancer, 2008
- A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage I–IV carcinosarcoma (CS) of the uterusGynecologic Oncology, 2007
- Uterine malignant mixed mullerian tumors should not be included in studies of endometrial carcinomaGynecologic Oncology, 2006
- Obesity: Preventing and Managing the Global Epidemic. Report of a WHO Consultation. WHO Technical Report Series 894. Pp. 252. (World Health Organization, Geneva, 2000.) SFr 56.00, ISBN 92-4-120894-5, paperback.Journal of Biosocial Science, 2003
- Bayes FactorsJournal of the American Statistical Association, 1995